Gene · 2072
Papers3,434
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,434
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cell membrane permeability and defective G2/M block as factors potentially contributing to increased cell chemosensitivity. SeAx cell line as an example. | Biochem Biophys Rep | 2021 | 34027132 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Chemotherapy Resistance in Head and Neck Cancers. | Front Oncol | 2021 | 34026617 | PubTator, text mining | PubMed |
| Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles. | EPMA J | 2021 | 34025826 | PubTator, text mining | PubMed |
| Developmental basis of trachea-esophageal birth defects. | Dev Biol | 2021 | 34023332 | PubTator, text mining | PubMed |
| Network-based analysis of key regulatory genes implicated in Type 2 Diabetes Mellitus and Recurrent Miscarriages in Turner Syndrome. | Sci Rep | 2021 | 34021221 | PubTator, text mining | PubMed |
| Decreased ATM Function Causes Delayed DNA Repair and Apoptosis in Common Variable Immunodeficiency Disorders. | J Clin Immunol | 2021 | 34009545 | PubTator, text mining | PubMed |
| DNA Repair Repertoire of the Enigmatic Hydra. | Front Genet | 2021 | 33995496 | PubTator, text mining | PubMed |
| Timely upstream events regulating nucleotide excision repair by ubiquitin-proteasome system: ubiquitin guides the way. | DNA Repair (Amst) | 2021 | 33991872 | PubTator, text mining | PubMed |
| Downregulation of both mismatch repair and non-homologous end-joining pathways in hypoxic brain tumour cell lines. | PeerJ | 2021 | 33986995 | PubTator, text mining | PubMed |
| Top1-PARP1 association and beyond: from DNA topology to break repair. | NAR Cancer | 2021 | 33981998 | PubTator, text mining | PubMed |
| Implications of the germline variants of DNA damage response genes detected by cancer precision medicine for radiological risk communication and cancer therapy decisions. | J Radiat Res | 2021 | 33978181 | PubTator, text mining | PubMed |
| A Nobel-Winning Scientist: Aziz Sancar and the Impact of his Work on the Molecular Pathology of Neoplastic Diseases. | Turk Patoloji Derg | 2021 | 33973640 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| The causes of Fanconi anemia in South Asia and the Middle East: A case series and review of the literature. | Mol Genet Genomic Med | 2021 | 33960719 | PubTator, text mining | PubMed |
| Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types. | Cancer Biol Med | 2021 | 33960179 | PubTator, text mining | PubMed |
| Spatial Distribution of Private Gene Mutations in Clear Cell Renal Cell Carcinoma. | Cancers (Basel) | 2021 | 33946379 | PubTator, text mining | PubMed |
| Cerebral venous sinus thrombosis in polycythemia vera patients with JAK2V617F mutation. | Chin Med J (Engl) | 2021 | 33941751 | PubTator, text mining | PubMed |
| The multi-functionality of UHRF1: epigenome maintenance and preservation of genome integrity. | Nucleic Acids Res | 2021 | 33939809 | PubTator, text mining | PubMed |
| The ZEB2-dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer. | Mol Oncol | 2021 | 33931939 | PubTator, text mining | PubMed |
| The association between XRCC3 rs1799794 polymorphism and cancer risk: a meta-analysis of 34 case-control studies. | BMC Med Genomics | 2021 | 33931047 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2072/papers?page=46